Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial. [electronic resource] by
- Sharma, Shrikant
- Singh, Veer Bahadur
- Kumar, Sanjay
- Prajapati, Vipul
- Patel, Jitendra
- Vukkala, Rajesh
- Jangid, Sanjay Kumar
- Sanmukhani, Jayesh
- Gupta, Gaurav
- Patel, Pradip
- Mittal, Ravindra
- Glueck, Reinhard
Producer: 20190128
In:
Human vaccines & immunotherapeutics vol. 14
Availability: No items available.
|